XML 39 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segment Information
9 Months Ended
Sep. 30, 2013
Business Segment Information

Note 2—Business segment information:

 

 

 

Business segment

  

Entity

  

% controlled at

September 30, 2013

 

Chemicals

  

Kronos

  

 

  80

%

Component products

  

CompX

  

 

  87

%

Waste management

  

WCS

  

 

  100

%

Our control of Kronos includes 50% we hold directly and 30% held directly by NL. We own 83% of NL. Our control of CompX is through NL. At  September 30, 2013 we had an aggregate of 12.0 million shares of our Kronos common stock pledged as collateral for certain debt obligations of Contran.  We receive a fee from Contran for pledging these Kronos shares, determined by a formula based on the market value of the shares pledged.

 

 

 

Three months ended

September 30,

 

 

Nine months ended

September 30,

 

 

2012

 

 

2013

 

 

2012

 

 

2013

 

 

(In millions)

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chemicals

$

  472.9

 

 

$

  419.1

 

 

$

  1,579.5

 

 

$

  1,363.8

 

Component products

 

  21.4

 

 

 

  24.2

 

 

 

  63.9

 

 

 

  69.7

 

Waste management

 

  14.5

 

 

 

  4.9

 

 

 

  16.5

 

 

 

  29.9

 

Total net sales

$

  508.8

 

 

$

  448.2

 

 

$

  1,659.9

 

 

$

  1,463.4

 

Cost of sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chemicals

$

  387.5

 

 

$

  372.4

 

 

$

  1,070.5

 

 

$

  1,304.8

 

Component products

 

  15.1

 

 

 

  16.7

 

 

 

  45.1

 

 

 

  48.6

 

Waste management

 

  8.7

 

 

 

  10.5

 

 

 

  24.4

 

 

 

  31.3

 

Total cost of sales

$

  411.3

 

 

$

  399.6

 

 

$

  1,140.0

 

 

$

  1,384.7

 

Gross margin:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chemicals

$

  85.4

 

 

$

  46.7

 

 

$

  509.0

 

 

$

  59.0

 

Component products

 

  6.3

 

 

 

  7.5

 

 

 

  18.8

 

 

 

  21.1

 

Waste management

 

  5.8

 

 

 

(5.6

)

 

 

(7.9

)

 

 

(1.4

)

Total gross margin

$

  97.5

 

 

$

  48.6

 

 

$

  519.9

 

 

$

  78.7

 

Operating income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chemicals

$

  40.4

 

 

$

(35.2

)

 

$

  364.1

 

 

$

(125.6

)

Component products

 

  1.7

 

 

 

  3.0

 

 

 

  5.4

 

 

 

  7.4

 

Waste management

 

(1.0

)

 

 

(10.3

)

 

 

(21.9

)

 

 

(16.3

)

Total operating income (loss)

 

  41.1

 

 

 

(42.5

)

 

 

  347.6

 

 

 

(134.5

)

Equity in earnings of investees

 

(.1

)

 

 

 

 

 

(.1

)

 

 

(.8

)

General corporate items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Securities earnings

 

  7.3

 

 

 

  6.6

 

 

 

  21.5

 

 

 

  19.9

 

Insurance recoveries

 

  1.2

 

 

 

  2.2

 

 

 

  2.6

 

 

 

  3.8

 

Litigation settlement gain

 

 

 

 

 

 

 

  14.7

 

 

 

 

Loss on prepayment of debt

 

 

 

 

(2.3

)

 

 

(7.2

)

 

 

(8.9

)

General expenses, net

 

(7.9

)

 

 

(10.1

)

 

 

(37.4

)

 

 

(41.4

)

Interest expense

 

(14.6

)

 

 

(13.7

)

 

 

(42.4

)

 

 

(43.8

)

Income (loss) from continuing operations before income taxes

$

  27.0

 

 

$

(59.8

)

 

$

  299.3

 

 

$

(205.7

)

Segment results we report may differ from amounts separately reported by our various subsidiaries and affiliates due to purchase accounting adjustments and related amortization or differences in the way we define operating income. Intersegment sales are not material.  The operating loss of our Chemicals Segment for the third quarter and first nine months of 2013 includes a $35 million charge related to a litigation settlement, see Note 16.